Avidity Partners Management LP Curis Inc Transaction History

Avidity Partners Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $15.3 Million - $33.4 Million	-2,053,789 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.78 - $12.8 $2.53 Million - $3.69 Million	-288,311 Reduced 12.31%	2,053,789 $23.2 Million
Q4 2020 Feb 16, 2021	BUY	$1.08 - $8.2 $2.53 Million - $19.2 Million	2,342,100 New	2,342,100 $19.2 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.